Oncotype Dx Recurrence Score - Invasive
This input is used for staging
Notes
**Note 1:** Physician statement of Oncotype Dx Recurrence Score-Invasive score can be used to code this data item. **Note 2:** The Oncotype Dx-Invasive recurrence score is reported as a whole number between 0 and 100. The actual recurrence score takes priority over codes XX4 and XX5. **Note 3:** Record only the results of an Oncotype Dx-Invasive recurrence score in this data item. If some other test is used for scoring, assign code XX9. **Note 4:** Predicted Oncotype Dx Recurrence Score based on linear regression models and Magee equations should not be reported in this field. * If the only information you have on Oncotype Dx is based on a linear regression model and Magee score, code unknown * Code the results of a Magee score in the Multigene Data Items: Multigene Signature Method [NAACCR Data Item #3894] and Multigene Signature Results [NAACCR Data Item #3895] **Note 5:** In cases where Oncotype DX is reported on more than one breast tumor specimen, record the highest value. **Note 6:** Results from nodal or metastatic tissue may be used, ONLY when there is no evidence of primary tumor. **Note 7:** Staging for Breast cancer now depends on the Oncotype-Dx-Invasive recurrence score. Score of less than 11 indicates a pertinent cut off value for staging purposes. **Note 8:** If the only information available is the Oncotype Dx-Invasive Risk Level, assign XX7. **Note 9:** Code this data item using the same report used to record Oncotype Dx Risk Level-Invasive [NAACCR Data Item #3906]Default
XX9NAACCR Item
NAACCR #3904Metadata
SSDI| Code | Description |
|---|---|
| 000-100 | Enter actual recurrence score between 0 and 100 |
| XX4 | Stated as less than 11 |
| XX5 | Stated as equal to or greater than 11 |
| XX6 | Not applicable, in situ case |
| XX7 | Test ordered, results not in chart |
| XX9 | Not documented in medical record Oncotype Dx Recurrence Score-Invasive not assessed or unknown if assessed |